Short postsurgical antibiotic therapy for spinal infections: protocol of prospective, randomized, unblinded, noninferiority trials (SASI trials)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Short postsurgical antibiotic therapy for spinal infections: protocol of prospective, randomized, unblinded, noninferiority trials (SASI trials) ; volume:21 ; number:1 ; day:6 ; month:2 ; year:2020 ; pages:1-11 ; date:12.2020
Trials ; 21, Heft 1 (6.2.2020), 1-11, 12.2020
- Creator
-
Betz, Michael
Uçkay, Ilker
Schüpbach, Regula
Gröber, Tanja
Botter, Sander M.
Burkhard, Jan
Holy, Dominique
Achermann, Yvonne
Farshad, Mazda
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13063-020-4047-3
- URN
-
urn:nbn:de:101:1-2020050806563069547503
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Betz, Michael
- Uçkay, Ilker
- Schüpbach, Regula
- Gröber, Tanja
- Botter, Sander M.
- Burkhard, Jan
- Holy, Dominique
- Achermann, Yvonne
- Farshad, Mazda
- SpringerLink (Online service)
Other Objects (12)
Noninferiority trials
Analyzing noninferiority trials: it is time for advantage deficit assessment – an observational study of published noninferiority trials
Interpreting the results of noninferiority trials—a review
Understanding the null hypothesis (H0) in non-inferiority trials
Evidence-based sizing of non-inferiority trials using decision models
Phase IV non-inferiority trials and additional claims of benefit
Is there a danger of “biocreep” with non-inferiority trials?
Maximum likelihood theory for retention of effect non-inferiority trials
Planning and analysis of two- and three-arm non-inferiority trials
The use of randomisation-based efficacy estimators in non-inferiority trials
Response to: Understanding the null hypothesis (H0) in non-inferiority trials
Intention-to-treat analysis may be more conservative than per protocol analysis in antibiotic non-inferiority trials: a systematic review
Noninferiority trials
Analyzing noninferiority trials: it is time for advantage deficit assessment – an observational study of published noninferiority trials
Interpreting the results of noninferiority trials—a review
Understanding the null hypothesis (H0) in non-inferiority trials
Evidence-based sizing of non-inferiority trials using decision models
Phase IV non-inferiority trials and additional claims of benefit
Is there a danger of “biocreep” with non-inferiority trials?
Maximum likelihood theory for retention of effect non-inferiority trials
Planning and analysis of two- and three-arm non-inferiority trials
The use of randomisation-based efficacy estimators in non-inferiority trials
Response to: Understanding the null hypothesis (H0) in non-inferiority trials
Intention-to-treat analysis may be more conservative than per protocol analysis in antibiotic non-inferiority trials: a systematic review
Noninferiority trials
Analyzing noninferiority trials: it is time for advantage deficit assessment – an observational study of published noninferiority trials
Interpreting the results of noninferiority trials—a review
Understanding the null hypothesis (H0) in non-inferiority trials
Evidence-based sizing of non-inferiority trials using decision models
Phase IV non-inferiority trials and additional claims of benefit
Is there a danger of “biocreep” with non-inferiority trials?
Maximum likelihood theory for retention of effect non-inferiority trials
Planning and analysis of two- and three-arm non-inferiority trials
The use of randomisation-based efficacy estimators in non-inferiority trials
Response to: Understanding the null hypothesis (H0) in non-inferiority trials